Taking Stock: Indian indices fall on weak Asian cues; pharma worst hit – Moneycontrol.com
On the BSE, healthcare and power indices lost 1.5-3 percent, while the metal index added 1.6 percent Read More
reported by at Moneycontrol
D-Street Buzz: Nifty Pharma falls more than 4%; Dr Reddy’s shares fall 10% – Moneycontrol.com
Shares of Dr Reddy’s Labs fell after the company posted a consolidated profit of Rs 570.8 crore for the quarter ended June 30, 2021, a 1.5 percent drop from the year-ago period Read More
reported by at Moneycontrol
IndiGo Q1 net loss widens to ₹3,179 cr as revenue hit by severe second Covid wave – Mint
The company’s revenue from operations plunged 48% quarter-on-quarter (QoQ) to ?3,0007 crore in Q1FY22 as against ?6,223 crore in Q4FY21.The company saw a 59% rise in total expenses in the quarter to ?6,344 crore Read More
reported by Aparna Banerjea at Livemint
Why Dr Reddy’s Lab shares hit 10% lower circuit today – Mint
Dr Reddy’s said it has received a subpoena from the US market regulator SEC for production of documents pertaining to CIS (Commonwealth of Independent States) geographies Read More
reported by Saloni Kothari at Livemint
Meet Anita Kishore: The Firm Hand Behind Byju’s Global Acquisitions – Forbes India
The maths teacher has been driving acquisitions, managing investor relations and framing strategies for Byju’s Read More
reported by at Forbesindia.com
Recent Comments